ArticleInvestigational new drugs2025
Linifanib alone and in combination with metronomic chemotherapy is active on cutaneous T-cell lymphoma cells by targeting the AKT/mTOR signaling pathway.
Marta Banchi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.